http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04145024-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
| filingDate | 1990-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e7e45de4deb604a7a11ca4caf2a1d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66623633a63c04bb40231db5a8c878fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc015415158d08cd816ecfa53ae7f085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a51f7de2436b36682e2b63299c2427 |
| publicationDate | 1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H04145024-A |
| titleOfInvention | Bone resorption suppressing agent |
| abstract | PURPOSE: To obtain a bone resorption suppressing agent exhibiting excellent bone resorption suppressing action, free from side effect such as estrogen action and useful for the remedy of osteoporosis by using an estradiol derivative as an active component. n CONSTITUTION: The objective agent can be prepared by using an estradiol derivative of formula (R 1 is H, alkyl or acyl; R 2 is H, alkyl or alkynyl; R 3 is alkyl, alkenyl, alkynyl or hydrocarbon group; R 4 is H or hydrocarbon group; etc.), its salt or its ester as an active component, properly adding pharmacologically permissible conventional additives and forming in the form of a drug preparation by conventional process. It can be used in the form of tablet, pill, granule, powder, capsule, syrup, emulsion, suspension, etc. It is administered at a daily dose of 0.01-30mg for adult in 1-3 divided doses. n COPYRIGHT: (C)1992,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100368103-B1 |
| priorityDate | 1990-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323 |
Total number of triples: 23.